| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:2270.)
© 2005 American Heart Association, Inc.
Original Contributions |
From the Division of Strokology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Correspondence to Kazuo Kitagawa, MD, PhD, Division of Strokology, Department of Cardiovascular Medicine (A8), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail kitagawa{at}medone.med.osaka-u.ac.jp
| Abstract |
|---|
|
|
|---|
Methods After attachment of a probe, the left common carotid artery (CCA) of C57BL/6 mice was occluded. The left middle cerebral artery (MCA) was subsequently occluded permanently on days 0, 1, 4, 14, and 28 (n=8 each). The change in cortical perfusion during MCA occlusion was recorded. A sham group of mice received only exposure of the CCA and MCA occlusion 14 days later. In apoE-knockout mice, the MCA was occluded 14 days after CCA occlusion or sham surgery. Infarct size and neurologic deficit were determined 4 days after MCA occlusion.
Results Mice that had 45% to 65% of baseline perfusion after CCA occlusion were used. Cortical perfusion after MCA occlusion was significantly preserved in day 14 (47±16%) and day 28 (46±7%) groups compared with day 0 (28±8%), day 1 (33±19%), day 4 (29±16%), and sham groups (32±9%). Infarct size and neurologic deficits were also attenuated in day 14 and day 28 groups compared with other groups. In apoE-knockout mice, there was no significant difference in perfusion, neurologic deficits, or infarction size between groups with and without CCA occlusion.
Conclusion Chronic mild reduction of perfusion pressure resulted in preservation of cortical perfusion and attenuation of infarct size after MCA occlusion. These responses of collaterals were impaired in apoE-knockout mice.
Key Words: chronic ischemia chronic perfusion collateral circulation focal ischemia ischemic tolerance
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Surgery
General anesthesia was induced with 4.0% halothane and maintained with 0.5% halothane with an open facemask. A polyacrylamide column with an inner diameter of 0.8 mm for measurement of cortical microperfusion by laser-Doppler flowmetry (Advance laser Flowmetry, model ALF-21; Advance Co) was attached with dental cement to the intact skull 3.5mm lateral to the bregma. Laser Doppler flowmetry is not quantitative, but provides a reliable estimate of relative cerebral blood flow. The residual zero flow signal at the time of killing was <2% of baseline perfusion level in a preliminary experiment (n=10). Therefore, we did not determine it in each mouse in the following experiments. Body temperature was monitored with a rectal thermometer and maintained at 37.0°C with a heat lamp.
Common Carotid Artery Occlusion
In the first experiment, in each of 50 C57BL/6 mice, the CCA was ligated and the change in cortical perfusion after CCA occlusion was recorded. Seven days later, mice were killed with an overdose of pentobarbital. The brains were removed, fixed by immersion in an alcohol-5% acetic acid solution for 5 hours at 4°C, dehydrated, and embedded in paraffin. Tissue sections (5 µm) were obtained every 1mm, beginning at the frontal pole, and were examined after conventional staining with hematoxylin and eosin (H&E). In the sections including the hippocampus, the terminal deoxynucleotidyltransferase (TdT)-mediated dUTP-biotin nick end-labeling (TUNEL) procedure was performed using the Apoptag in situ Detection Kit (Chemicon). In another 8 mice that had 45% to 65% of baseline perfusion after CCA occlusion, the cortical perfusion recordings were measured at 2 hours and 1, 4, 14, and 28 days after CCA occlusion. The change of cortical perfusion after sham surgery was also recorded in the other 8 mice. The level of cortical perfusion was expressed as a percentage of the baseline value.
Middle Cerebral Artery Occlusion Subsequent to Common Carotid Artery Occlusion
In the second experiment, the CCA was ligated under halothane anesthesia. In mice that had 45% to 65% of baseline cortical perfusion after CCA occlusion, the MCA was occluded using electrocoagulation as described previously8 on days 0, 1, 4, 14, and 28 (n=8 each). Sham-group mice (n=8) received only exposure of CCA and MCA occlusion 14 days later. Mice were placed in the recumbent position, and a vertical skin incision was made at the midpoint between the left orbit and the external auditory canal. The mandible was pulled downward to expose the skull base. A small burr hole was made in the skull over the left MCA. The MCA was permanently occluded with a microbipolar electrocoagulator just proximal to the point where the olfactory branch came off. Cortical perfusion was monitored under halothane anesthesia for 15 minutes after MCA occlusion. Four days after MCA occlusion, mice were evaluated for neurologic deficits by a blind observer. The neurologic deficit score assignment of 0 to 4 was based on methods described previously by Yang et al9: 0, no neurologic deficits; 1, failed to extend right forepaw while held by the tail; 2, circled to the right; 3, fell to the right; or 4, unable to walk spontaneously. Then, mice were killed under pentobarbital anesthesia, and their brains were removed, fixed, and embedded in paraffin. The volume of infarction was measured using MCID Image Analysis Software (Imaging Research). The volume (mm3) was determined by integrating the appropriate area and the section thickness. To visualize the capillary perfusion, we labeled plasma with dichrolotriazinyl amino fluorescein (DTAF; excitation 489 nm, emission 515 nm; Sigma-Aldrich) as described previously.8 After MCA occlusion for 6 hours in mice with CCA occlusion or sham operation 14 days earlier, 50 µL of DTAF conjugated to mouse serum was injected for 10 seconds into the saphenous vein. Thirty seconds after completion of the injection, each mouse was decapitated and the brains were fixed in 80% ethanol for 24 hours. Brain slices, 50 µm in thickness, were prepared with a vibratome and examined under a fluorescence microscope. In mice with CCA occlusion or sham operation 14 days earlier (n=5 each), a femoral artery was cannulated with a PE-10 polyethylene tube at the time of MCA occlusion. Blood pH, PaO2, and PaCO2 were measured using the Acid-Base Laboratory system (ABL550; Radiometer).
Effect of Common Carotid Artery Occlusion in apoE-Knockout Mice
In the last experiment, we used apoE-knockout mice. The left CCA of apoE-knockout mice (n=8) was ligated under halothane anesthesia. Fourteen days later, the left MCA was permanently occluded. Sham-group mice (n=8) received only exposure of the left CCA and occlusion of the left MCA 14 days later. Four days after MCA occlusion, mice were evaluated for neurologic deficits, and they were killed and their brains were examined for infarction size. The experiment schedule is shown in Figure 1.
|
Statistics
All values are presented as mean±standard deviation. One-way analysis of variance (ANOVA) was performed with Scheffes multiple comparisons test to assess differences in perfusion change, neurologic deficit, score and infarct size between day 0, day 1, day 4, day 14, day 28, and sham groups. The perfusion values after CCA occlusion were analyzed by repeated-measures ANOVA followed by a post hoc Dunnett test. A MannWhitney U test was performed to assess differences between 2 groups of apoE-knockout mice. Pearsons test was used to evaluate the relationship between perfusion change after CCA occlusion and that after MCA occlusion. P<0.05 was considered significant. All statistical analyses were conducted using SPSS/Windows software, version 11.5J (SPSS Japan Inc).
| Results |
|---|
|
|
|---|
|
The change in the cortical perfusion after MCA occlusion compared with that before CCA operation, the perfusion change at the time of MCA occlusion, neurologic deficit score, and infarct size 4 days after MCA occlusion are shown for each group in Figure 3. CCA occlusion and subsequent MCA occlusion reduced perfusion to 15% to 20% in day 0, day 1, and day 4 groups (Figure 3A). However, in day 14 and day 28 groups, the change in perfusion after CCA and MCA occlusion were approximately 30% and were significantly higher than those of day 0, day 1, and day 4 groups (Figure 3A). In the sham-operation group, the change in perfusion after sham CCA operation and MCA occlusion was 31.8±9.0%, higher than those in day 0, day 1, and day 4 groups but not significant different compared with those in day 14 and day 28 groups (Figure 3A). At the time of MCA occlusion, cortical perfusion reduced to approximately 30% of baseline in day 0, day 1, day 4, and sham CCA exposure groups (Figure 3B). However, in day 14 and day 28 groups, the changes in perfusion at the time of MCA occlusion were 47.6±15.8% and 46.1±6.7%, respectively, and were significantly preserved compared with other groups (Figure 3B). In day 14 and day 28 groups (n=16), there was significantly negative correlation between the perfusion change after CCA occlusion and that at the time of MCA occlusion (r=0.686, P<0.01). Both neurologic deficit score (Figure 3C) and infarction size (Figures 3D and 4
) were significantly attenuated in day 14 and day 28 groups compared with other groups. Reduction of infarction size was markedly observed in the cerebral cortex (Figures 3D and 4
). Capillary fluorescence was hardly observed in the center of the MCA territory in sham operation group (Figure 4). In contrast, capillary perfusion in the same territory was better preserved in day 14 group (Figure 4). The physiological variables were determined for mean arterial blood pressure (day 14 group, 76.6±4.3 mm Hg; sham operation group, 77.0±3.4 mm Hg), PaCO2 (day 14 group, 35.2±3.3 mm Hg; sham operation group, 34.4±2.8 mm Hg), PaO2 (day 14 group, 119.6±9.2 mm Hg; sham operation group, 120.2±8.8 mm Hg), and pH (day 14 group, 7.29±0.07; sham operation group, 7.32±0.04 mm Hg). There were no significant differences in any of the variables between day 14 and sham-operation groups.
|
|
In apoE-knockout mice, the change in cortical perfusion, the neurologic score, and infarct size are shown in Figure 5. In apoE-knockout mice, the CCA occlusion treatment group (n=8) and the sham CCA exposure group (n=8) showed no significant difference in cortical microperfusion after CCA occlusion and subsequent MCA occlusion (29.5±9.0% compared with 30.4±8.5%), perfusion change at the time of MCA occlusion (36.4±11.8% compared with 30.2±7.8%), in neurologic scores (1.5±0.8 compared with 1.9±1.0), or in infarct size (31.5±8.2 mm3 compared with 37.0±5.3 mm3, P=0.14).
|
| Discussion |
|---|
|
|
|---|
Recently, arteriogenesis at the circle of Willis has been demonstrated clearly in a 3-vessel (1 carotid plus both vertebral arteries) occlusion model.3 Although reduction of perfusion pressure promotes arteriogenesis at the circle of Willis and in the distal anastomoses that have been described as "pre-existing collateral arterioles,"15 the diameters of leptomeningeal anastomoses in the 3-vessel occlusion model did not change.3 The estimation of vessel diameters may be insufficient for assessing collateral development, particularly in the ischemic condition. Resting cortical perfusion level remained 60% of baseline up to day 28 after CCA occlusion (Figure 2C), suggesting us to use a functional evaluation of collateral circulation by measuring the cortical perfusion at the time of MCA occlusion. We first examined the effect of unilateral CCA occlusion on cortical perfusion and histologic damage. Very few mice (6 of 50) showed moderate to severe ischemia (<35% of baseline) after unilateral CCA occlusion, and only 3 of them had histologic damage in the affected hemisphere. Therefore, in the present study, we used mice that showed 45% to 65% of baseline cortical perfusion.
Our results demonstrated that unilateral CCA occlusion treatment given 14 days before MCA occlusion preserved cortical perfusion and reduced infarct size markedly in the cerebral cortex after MCA occlusion. Negative correlation between changes in perfusion after the first CCA occlusion and at the time of subsequent MCA occlusion in day 14 and day 28 groups suggests that sufficient reduction of perfusion pressure is needed for collateral development. The time required to develop the effects in the present study is in agreement with the findings about collateral vessel development in hindlimb ischemia models.16 In general, the development of preexisting collateral arterioles into large conductance vessels may take days to weeks after a critical stenosis of the proximal artery.15 A direct neuroprotective preconditioning effect after chronic ischemia as shown in the previous study17 may in part contribute to the effect in day 14 and day 28 groups. Furthermore, coagulation status such as platelet accumulation and fibrin deposition may change after chronic ischemia as suggested in hypoxia-tolerant states.18
Because several studies demonstrated that disordered lipid metabolism may impair collateral vessel growth and angiogenesis in other organs,6 we examined the effect of unilateral CCA occlusion in apoE-knockout mice. We found that collateral development was impaired in apoE-knockout mice, suggesting that common mechanisms underlie arteriogenesis in the brain and systemic circulation. Based on the previous findings, possible mechanisms of collateral development after chronic hypoperfusion would be (1) fluid shear stress leading to endothelial activation, (2) monocyte invasion, and (3) proliferation of smooth muscle cells and vessel enlargement.19 Involvement of growth factors or cytokines such as VEGF6 and granulocyte-macrophage colony-stimulating factor20 in collateral development in the brain will need to be investigated further.
Endogenous adaptive responses to ischemic insults such as ischemic tolerance21 have received much attention, and it is widely believed that this phenomenon is largely the result of an endogenous response such as gene expression in the preconditioned neuron.22,23 However, vessel components should also be targets for investigation of endogenous response. Thus, we have clarified that chronic mild reduction of perfusion pressure leads to collateral development and brain protection after focal cerebral ischemia.
| Acknowledgments |
|---|
Received January 18, 2005; revision received June 22, 2005; accepted July 6, 2005.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Bevan, M. Dichgans, A. Gschwendtner, G. Kuhlenbaumer, E.B. Ringelstein, and H. S. Markus Variation in the PDE4D Gene and Ischemic Stroke Risk: A Systematic Review and Meta-analysis on 5200 Cases and 6600 Controls Stroke, July 1, 2008; 39(7): 1966 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Y Bang, J L Saver, B H Buck, J R Alger, S Starkman, B Ovbiagele, D Kim, R Jahan, G R Duckwiler, S R Yoon, et al. Impact of collateral flow on tissue fate in acute ischaemic stroke J. Neurol. Neurosurg. Psychiatry, June 1, 2008; 79(6): 625 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Todo, K. Kitagawa, T. Sasaki, E. Omura-Matsuoka, Y. Terasaki, N. Oyama, Y. Yagita, and M. Hori Granulocyte-Macrophage Colony-Stimulating Factor Enhances Leptomeningeal Collateral Growth Induced by Common Carotid Artery Occlusion Stroke, June 1, 2008; 39(6): 1875 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Obrenovitch Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia Physiol Rev, January 1, 2008; 88(1): 211 - 247. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |